AI drug discovery comes of age
Bringing a new drug to the clinic is a tortuous and extremely expensive process fraught with commercial risk. It seems that Artificial...
Daniel Rowe graduated from the University of Bristol with a First Class Honours Degree in Biochemistry. He has since been awarded a PhD by the University of Bristol for his research into the intracellular mechanisms underlying vein graft failure. He has the Certificate in Intellectual Property Law from Queen Mary College, University of London.
Inspired thinking – providing fresh insight to the world of IP
Bringing a new drug to the clinic is a tortuous and extremely expensive process fraught with commercial risk. It seems that Artificial...
The EPO’s practice on double patenting has been rather settled over the past decade. As indicated in the EPO’s Guidelines for...
A recent landmark decision of the Court of Justice of the European Union (CJEU) on the use of gene editing technologies to create new...
Yesterday I attended LSPN’s spring North America meeting, and what a stimulating and valuable event it was. Gathered together was a...
As reported earlier, signs that a CRISPR patent pool could be on the horizon have been appearing over the past few months. The Broad...
As a free user, you can follow Passle and like posts.
To repost this post to your own Passle blog, you will need to upgrade your account.
For plans and pricing, please contact our sales team at sales@passle.net
Search site
Contact our offices